Acquiring Company
Alfasigma
Acquired Company
Nordic Group B.V
Bologna
Easttown TownshipManufacturingBiotechnologyHealth CareBiotechnologyHealth CareDescription
Alfasigma S.p.A. has announced its acquisition of Nordic Group B.V., a move that strengthens its specialty care portfolio. This deal involves the purchase of 100% of Nordic Pharma's shares and its subsidiaries. The acquisition aims to enhance Alfasigma's presence in Europe and expand its offerings in the pharmaceutical market. The agreement highlights Alfasigma's commitment to improving patient care.
Who to call at Alfasigma, and when
When Alfasigma changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Alfasigma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alfasigma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alfasigma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alfasigma makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Nordic Group B.V?
Nordic Group B.V was acquired by Alfasigma, based in Bologna. The deal was reported on August 11, 2026. Alfasigma is one of Italy's leading pharmaceutical companies with a strong international position. Alfasigma is privately held and operates in Manufacturing.
When did Alfasigma acquire Nordic Group B.V?
Alfasigma's acquisition of Nordic Group B.V was reported on August 11, 2026. Alfasigma S.p.A. has announced its acquisition of Nordic Group B.V., a move that strengthens its specialty care portfolio. This deal involves the purchase of 100% of Nordic Pharma's shares and its subsidiaries. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Nordic Group B.V do?
Nordic Pharma, Inc. is a US-based subsidiary of Nordic Group B.V. that specializes in innovative therapies for ophthalmological conditions. They recently launched LACRIFILL® Canalicular Gel, a novel treatment for dry eyes. It is privately held, operating in Biotechnology, and is based in Easttown Township.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.